1. Home
  2. LEXX vs IZM Comparison

LEXX vs IZM Comparison

Compare LEXX & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • IZM
  • Stock Information
  • Founded
  • LEXX 2004
  • IZM 2011
  • Country
  • LEXX Canada
  • IZM China
  • Employees
  • LEXX N/A
  • IZM N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • IZM Consumer Electronics/Video Chains
  • Sector
  • LEXX Health Care
  • IZM Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • IZM Nasdaq
  • Market Cap
  • LEXX 20.9M
  • IZM 21.1M
  • IPO Year
  • LEXX N/A
  • IZM 2023
  • Fundamental
  • Price
  • LEXX $0.98
  • IZM $2.33
  • Analyst Decision
  • LEXX Strong Buy
  • IZM
  • Analyst Count
  • LEXX 1
  • IZM 0
  • Target Price
  • LEXX $7.00
  • IZM N/A
  • AVG Volume (30 Days)
  • LEXX 90.9K
  • IZM 32.4K
  • Earning Date
  • LEXX 07-11-2025
  • IZM 07-25-2025
  • Dividend Yield
  • LEXX N/A
  • IZM N/A
  • EPS Growth
  • LEXX N/A
  • IZM N/A
  • EPS
  • LEXX N/A
  • IZM N/A
  • Revenue
  • LEXX $525,923.00
  • IZM $177,933,890.00
  • Revenue This Year
  • LEXX $0.62
  • IZM N/A
  • Revenue Next Year
  • LEXX $14.19
  • IZM N/A
  • P/E Ratio
  • LEXX N/A
  • IZM N/A
  • Revenue Growth
  • LEXX 29.95
  • IZM N/A
  • 52 Week Low
  • LEXX $0.95
  • IZM $1.18
  • 52 Week High
  • LEXX $4.44
  • IZM $3.19
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 38.55
  • IZM 58.92
  • Support Level
  • LEXX $1.00
  • IZM $2.26
  • Resistance Level
  • LEXX $1.05
  • IZM $2.49
  • Average True Range (ATR)
  • LEXX 0.05
  • IZM 0.12
  • MACD
  • LEXX 0.01
  • IZM -0.02
  • Stochastic Oscillator
  • LEXX 28.80
  • IZM 48.00

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

Share on Social Networks: